AAV gene therapy
Tuberous sclerosis (TSC) 1/2
estimated prevalence
100,000
Disease
Tuberous sclerosis (TSC) 1/2
Genetic Source
TSC
Clinical Phase
Pre-clinical
Modality
gene therapy